![Christopher Ngai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Ngai
Corporate Officer/Principal presso
CALLIDITAS THERAPEUTICS AB
Profilo
Christopher Ngai currently works at Calliditas Therapeutics AB, as Vice President-US Market Access from 2020.
Mr. Ngai received his graduate degree from the University of Toronto.
Posizioni attive di Christopher Ngai
| Società | Posizione | Inizio |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | 01/04/2020 |
Formazione di Christopher Ngai
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
26
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calliditas Therapeutics AB
 Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
